grapiprant
Commercial- Indications
- Canine osteoarthritis
Company intelligence / Profile preview
Aratana Therapeutics
Leawood, Kansas, USAaratana.investorroom.com ↗
- Ownership
- Private
- Employees
- ~125
- Development stage
- Commercial
01
Overview
Aratana successfully developed and commercialized three FDA-approved therapeutics for companion animals—Galliprant®, Entyce®, and Nocita®. The company also advanced a diverse pipeline targeting unmet needs such as oncology, dermatology, virology, regenerative medicine, and more. Its products are now part of Elanco’s portfolio following the 2019 acquisition.
- Therapeutic areas
- OncologyImmunologyOtherDermatologyRheumatologyGastroenterologyOphthalmology
- Modalities
- Small moleculeBiologicAllogeneic adipose-derived stem cell therapyRecombinant proteinLiposome formulationVaccineAntiviral small molecule
- Industry
- Veterinary
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Elanco Animal HealthPacira PharmaceuticalsAskAt Inc
Beyond the preview
Go deeper on Aratana Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aratana Therapeutics.